[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more SOLO DMPK & Bioanalysis is a complete panel for the evaluation and characterization of ADME-T (Absorption, Distribution, Metabolism, Excretion and Toxicity), pharmacokinetic, regulatory and non-regulatory bioanalytical support of your chemical or biological molecules. It is an integral part of the discovery and development pathway of new therapeutic entities from the early Hit Finding phase, the selection of preclinical drug candidates and up to the submission of the IND /CTA dossier before clinical entry.
Evaluation of physicochemical and in vitro ADME properties
Optimization of physicochemical and drug-like properties
Optimization of drug-like properties, IVIVC, PK/PD correlation
Dose range finding, safety/tox evaluation, human dose prediction
Based on our experience in a large number of drug candidate discovery projects, SOLO DMPK & Bioanalysis is an expert solution to guide the characterization of the developability of new therapeutic molecules:
We offer specialized support in regulatory bioanalysis from preclinical to clinical development of new and various chemical and biological entities. GLP analysis by mass spectrometry, quantitative PCR, flow cytometry and ligand binding assays are an integral part of our established expertise and know-how.